Print Page      Close Window     

Events Calendar

June 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-4-3-2-112
June 02, 2017
8-K
Formats:  Excel HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
3
45678
June 08, 2017
4
Formats:  HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
9
June 09, 2017
8-K
Formats:  Excel HTML Adobe PDF Word
10
11121314151617
18192021
June 21, 2017
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
222324
25262728293051
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.
Upcoming Events
DateTitleRemind MePrior to Event
06/22/17
Spark Therapeutics, Inc. at J.P. Morgan European Healthcare Conference
Location: London
  
Past Events
DateTitle
06/14/17
4:00 p.m. PT
Spark Therapeutics, Inc. at Goldman Sachs 38th Annual Global Healthcare Conference
Location: Terranea Resort
Rancho Palos Verdes, CA
06/06/17
4:00 p.m. ET
Spark Therapeutics, Inc. at Jefferies 2017 Healthcare Conference
Location: Grand Hyatt
, NY
05/09/17
8:30 a.m. ET
Q1 2017 Spark Therapeutics, Inc. Earnings Conference Call
05/09/17 through 05/13/17
Spark Therapeutics, Inc. at American Society of Gene & Cell Therapy 2017 Annual Meeting
Description:
  • Katherine A. High, M.D., president and chief scientific officer, will present on “Clinical-Development Pathways in Gene-based Therapeutics,” as part of the Clinical Pathways from Lab to (Almost) Licensure session on Tuesday, May 9, from 2:20 to 4 p.m. EDT
  • Xavier M. Anguela, Ph.D., head of discovery, will present “SPK-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B at the Low Vector Dose Achieved Sustained, Continuous Factor IX Activity Levels Adequate for Endogenous Prophylaxis Preventing Bleeding Episodes and Reducing the Risk of Immune Response,” during the Clinical Trials Spotlight Symposium on Saturday, May 13, from 8:15 to 8:35 a.m. EDT.
Location: Marriott Wardman Park Hotel
Washington, DC
05/08/17 through 05/10/17
Spark Therapeutics, Inc. at Association for Research in Vision and Ophthalmology (ARVO) 2017 Annual Meeting
Description:
  • Kathleen Z. Reape, M.D., head of clinical R&D, will present data on the “Natural History of Individuals with Retinal Degeneration Due to Biallelic Mutations in the RPE65 Gene,” on Monday, May 8, from 8:30 to 10:15 p.m. EDT.
  • Daniel C. Chung, D.O., M.A., clinical ophthalmic lead, will present data on the “Correlation of multi-luminance mobility testing with visual function tests in a Phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease,” on Tuesday, May 9, between 11 a.m. - 12:45 p.m. EDT.
  • Stephen R. Russell, M.D., clinical director of the Stephen A. Wynn Institute for Vision Research, University of Iowa, will present “Year 2 results for a Phase 3 trial of voretigene neparvovec in biallelic RPE65-mediated inherited retinal disease,” on Wednesday, May 10, from 8:30 to 10:15 a.m. EDT.
  • Tomas S. Aleman, M.D., associate professor of ophthalmology at the Perelman School of Medicine, University of Pennsylvania, will present “AAV2-hCHM Subretinal Delivery to the Macula in Choroideremia: Preliminary Six Month Safety Results of an Ongoing Phase I/II Gene Therapy Trial” on Wednesday, May 10, from 11:00 a.m. to 12:45 p.m. EDT.
Location: Baltimore Convention Center
03/15/17
4:20 p.m. ET
Spark Therapeutics, Inc. at Barclays Global Healthcare Conference
Location: Loews Miami Beach Hotel
Miami, FL
03/06/17
3:20 p.m. ET
Spark Therapeutics, Inc. at Cowen and Company 37th Annual Health Care Conference
Location: Boston Marriott Copley Place
Boston, MA
02/23/17
Spark Therapeutics, Inc. at RBC Capital Markets Global Healthcare Conference
Location: New York, NY
02/22/17
8:30 a.m. ET
Q4 2016 Spark Therapeutics, Inc. Earnings Conference Call
02/14/17
12:00 p.m. ET
Spark Therapeutics, Inc. at BIO CEO & Investor Conference
Description: Katherine A. High, M.D., president and chief scientific officer, will participate in a Fireside Chat on how Spark Therapeutics, a fully integrated gene therapy company, is creating a value-driven approach in a new field of science and technology on Tuesday, Feb. 14, at 12 p.m. EST
Location: The Waldorf Astoria
New York, NY
02/14/17
Spark Therapeutics, Inc. at SunTrust Robinson Humphrey 2017 Orphan Drug Day
Location: New York, NY
02/01/17
2:00 p.m. CT
Spark Therapeutics, Inc. at European Association for Haemophilia and Allied Disorders (EAHAD)
Description:
  • Katherine A. High, M.D., president and chief scientific officer, will participate in the Pfizer Corporate Symposium on Wednesday, Feb. 1, at 2 p.m. CET
  • Marcus Carr, M.D., head of clinical development, will present previously disclosed data during a presentation on “Preliminary Interim Data from Phase 1/2 Trial: SPK-9001 Adeno-associated Virus Mediated Gene Transfer for Haemophilia B Achieves Sustained Therapeutic Factor IX Activity Levels Without Repetitive Infusions” at the Hot Topics session on Friday, Feb. 3, at 12:30 p.m. CET
Location: Marriott Rive Gauche Hotel & Conference Centre
Paris FR
01/10/17
11:30 a.m. PT
Spark Therapeutics, Inc. at 35th Annual J.P. Morgan Healthcare Conference
Description: Click here for Q&A replay.
12/04/16
2:00 p.m. PT
Spark Therapeutics, Inc. at 58th American Society of Hematology (ASH) Annual Meeting
Description:

SPK-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of >30% without Immunosuppression (Abstract # 91358)

Presenter: Lindsey George, M.D., Children's Hospital of Philadelphia
Date: Sunday, Dec. 4, 2016 
Session time: 2-4 p.m. PST
Location: San Diego Convention Center, Hall AB

Location: San Diego Convention Center, Hall AB
San Diego, CA
11/17/16
8:00 a.m. GMT
Spark Therapeutics, Inc. at Jefferies 2016 London Healthcare Conference
Description: Stephen Webster, chief financial officer, will present on Thursday, Nov. 17, at 8 a.m. GST
Location: Waldorf Hilton
London GB
11/16/16
3:00 p.m. ET
Spark Therapeutics, Inc. at Stifel 2016 Healthcare Conference
Description: Stephen Webster, chief financial officer, will present on Wednesday, Nov. 16, at 3 p.m. EST
Location: Lotte New York Palace Hotel
New York City, NY
11/10/16
10:25 a.m. ET
Spark Therapeutics, Inc. at Retina International Interdisciplinary Open Workshop
Location: National 4-H Conference Center
Chevy Chase, MD
11/09/16
2:05 p.m. ET
Spark Therapeutics, Inc. at NEI/FDA Endpoints Workshop
Description: Albert M. Maguire, M.D., professor of ophthalmology at the Perelman School of Medicine of the University of Pennsylvania and principal investigator in the clinical trials of Spark Therapeutics’ investigational therapy voretigene neparvovec, will give a presentation entitled “Endpoints for Gene Therapy Clinical Trials – Low Luminance Mobility Maze”, on Wednesday, Nov. 9, at 2:05 p.m. EST
Location: Lister Hill Center – NIH Campus
Bethesda, MD
11/08/16
1:30 p.m. MT
Spark Therapeutics, Inc. at Credit Suisse 25th Annual Healthcare Conference
Description: Jeffrey D. Marrazzo, chief executive officer, will present on Tuesday, Nov. 8, at 1:30 p.m. MST
Location: The Phoenician
Scottsdale, AZ
11/04/16
3:45 p.m. CT
Spark Therapeutics, Inc. at Genome Editing for Gene and Cell Therapy, a Herrenhausen Symposium
Description: Katherine High, M.D., president and chief scientific officer, will participate in a panel discussion entitled “Therapeutics” on Thursday, Nov. 3, at 2:15 p.m. CET, and will give a presentation entitled “AAV-Mediated Gene Therapy for Genetic Disease” on Friday, Nov. 4 at 3:45 p.m. CET
Location: Herrenhausen Palace Conference Center
Hanover DE
11/04/16
1:30 p.m. GMT
Spark Therapeutics, Inc. at Oxford Global 2nd Annual Cell & Gene Therapy Congress
Location: Radisson Blue
London GB
11/03/16
8:30 a.m. ET
Q3 2016 Spark Therapeutics, Inc. Earnings Conference Call
10/20/16
10:30 a.m. CT
Spark Therapeutics, Inc. at 2016 European Society of Gene & Cell Therapy (ESGCT)
Description: Katherine High, M.D., president and chief scientific officer, will participate in the In vivo Gene Therapy session on Thursday, Oct. 20, at 10:30 a.m. (CET)
Location: Palazzo dei Congressi e degli Affari
Florence IT
10/18/16
11:00 a.m. ET
Spark Therapeutics, Inc. at MIT Review emTech Conference
Description: Katherine High, M.D., president and chief scientific officer, will speak about “Gene Therapy - A New Era of Medicine” on Tuesday, Oct. 18, at 11 a.m. (EDT)
Location: MIT Media Lab
Boston, MA
10/17/16
11:00 a.m. ET
Spark Therapeutics, Inc. at 2016 NORD Rare Diseases & Orphan Products Breakthrough Summit 2016
Description: Jeffrey D. Marrazzo, chief executive officer, will participate in the "Potential Advances Through Genetic Innovation" panel discussion, on Monday, Oct. 17, at 11 a.m. (EDT)
Location: Hyatt Regency Crystal City
Arlington, VA
10/14/16
12:13 p.m. CT
Spark Therapeutics, Inc. at Retina Days Subspecialty Meeting
Description: Albert M. Maguire, M.D., professor of ophthalmology at the Perelman School of Medicine of the University of Pennsylvania, will talk about “Gene Therapy for Leber Amaurosis Type 2 – Clinical Trials Results,” including data from the pivotal Phase 3 trial of voretigene neparvovec on Friday, Oct. 14, at 12:13 p.m. (CDT).
Location: McCormick Center in Chicago
10/13/16
7:30 a.m. CT
Spark Therapeutics, Inc. at 2016 Ophthalmology Innovation Summit
Description: Jeffrey D. Marrazzo, chief executive officer, will participate in the Gene Therapy Breakfast Break-Out Panel discussion on Thursday, Oct. 13, at 7:30 a.m. (CDT).
Location: Hyatt Regency Chicago
10/11/16
Spark Therapeutics, Inc. at Jefferies Gene Editing/Gene Therapy Summit
Description: Company representatives will attend the conference for one-on-one meetings.
Location: Jefferies Conference Center
New York, NY
10/05/16
5:56 p.m. CT
Spark Therapeutics, Inc. at 2016 European Association for Vision and Eye Research (EVER) Congress
Description: Bart Leroy, M.D., director of the Ophthalmic Genetics and Retinal Degenerations clinics in the Division of Ophthalmology and Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, will speak about “Current gene therapy trials for inherited retinal disorders” on Wednesday, Oct. 5, at 5:56 p.m. (CET). Dr. Leroy is an investigator in the clinical development program for voretigene neparvovec, Spark Therapeutics’ lead investigational gene therapy for RPE-65 mediated inherited retinal disease.
Location: Acropolis Convention Center
Nice FR
10/03/16
12:50 p.m. ET
Spark Therapeutics, Inc. at XII International Conference of the Argentinian Society of Retina and Vitreous
Description: Paolo Falabella, M.D., Medical Affairs Ophthalmic Lead, will talk about “Investigational ocular gene therapy for RPE65-mediated retinal dystrophy” on Monday, Oct. 3, at 12:50 p.m. (EDT)
Location: Hotel Arakur
Ushuaia AR
09/28/16
3:40 p.m. ET
Spark Therapeutics, Inc. at 2016 Leerink Partners Rare Disease Roundtable Series
Description: Stephen Webster, chief financial officer, will participate in the Rare Disease and Immuno-Oncology roundtable discussion on Wednesday, Sept. 28, at 3:40 p.m. (EDT)
Location: Lotte NY Palace
New York, NY
09/14/16
Spark Therapeutics, Inc. at Bank of America / Merrill Lynch (BAML) Global HC Conference 2016
Location: BOA/ML Financial Centre
London GB
09/09/16
5:24 p.m. CET
Spark Therapeutics, Inc. at 16th Congress of the European Retina, Macula and Vitreous Society (EURETINA)
Location: Bella Center
Copenhagen DK
09/09/16
Spark Therapeutics, Inc. at Goldman Sachs 6th Annual Biotech Symposium
Location: Goldman Sachs’ Office
London GB
09/07/16
4:55 p.m. ET
Spark Therapeutics, Inc. at Baird 2016 Global Healthcare Conference
09/07/16
1:00 p.m. ET
Spark Therapeutics, Inc. at Citibank’s 11th Annual Biotech Conference
08/10/16
8:30 a.m. ET
Q2 2016 Spark Therapeutics, Inc. Earnings Conference Call
07/25/16
4:00 p.m. ET
World Federation of Hemophilia (WFH) 2016 World Congress
Description:

Dr. Lindsey George, a hematologist at the Children's Hospital of Philadelphia and the lead clinical investigator in the Phase 1/2 clinical trial of SPK-9001 for the treatment of hemophilia B, will present a moderated poster presentation on Monday July 25, 2016 at 4:00 pm (ET)

Dr. George also will present at a late-breaking abstract session on gene therapy on Wednesday July 27, 2016 at 2:15 pm (ET).

07/13/16
10:45 a.m. ET
Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Description: Stephen Webster, Spark’s chief financial officer, will present on Wednesday July 13, 2016 at 10:45 am (ET) and also will participate in a gene therapy panel at 12:15 pm (ET)
06/23/16
Spark Therapeutics Inc at J.P. Morgan 4th Annual European Healthcare Conference
06/22/16
Spark Therapeutics, Inc. at Roth Capital Partners 3rd Annual ROTH Healthcare Day
06/13/16
8:30 a.m. ET
Spark Therapeutics, Inc. Call to Discuss Hemophilia Franchise
06/11/16
Spark Therapeutics, Inc. at European Hematology Association
Description:

Dr. Katherine High will present at the European Hematology Association press briefing on Saturday June 11, 2016, at 8:30 am Central European Time (CET), and Dr. Spencer Sullivan, clinical investigator on the trial, will present the abstract data on June 11 at 5:30 pm (CET), in Copenhagen, Denmark.

06/10/16
2:00 p.m. ET
Spark Therapeutics, Inc. at Jefferies 2016 Healthcare Conference
06/07/16
4:00 p.m. ET
Spark Therapeutics, Inc. at Goldman Sachs 37th Annual Global Healthcare Conference
06/07/16 through 06/09/16
Spark Therapeutics, Inc. at 2016 BIO International Convention
Description:
  • Dr. Daniel Takefman, head of regulatory affairs; Genetic Medicines Come of Age: The Challenges and Opportunities; Tuesday June 7, 2016, at 2:15 pm (PT)
  • Jeffrey D. Marrazzo, chief executive officer; Curative Therapies: Aligning Policy with Science to Ensure Patient Access; Wednesday June 8, 2016, at 10:45 am (PT)
  • Dr. Katherine High, president and chief scientific officer; Gene Therapy or CRISPR: Which One Will Change the Future of Medical Care?; Thursday June 9, 2016, at 9:00 am (PT)
05/23/16
Spark Therapeutics, Inc. at UBS 2016 Global Healthcare Conference
05/17/16
Spark Therapeutics, Inc. at Piper Jaffray GenomeRX Symposium
05/04/16
8:30 a.m. ET
Q1 2016 Spark Therapeutics, Inc. Earnings Conference Call
05/04/16
8:00 a.m. ET
Spark Therapeutics, Inc. at Deutsche Bank 41st Annual Healthcare Conference
03/09/16
8:30 a.m. ET
Q4 2015 Spark Therapeutics, Inc. Earnings Conference Call
01/11/16
4:30 p.m. PT
Spark Therapeutics, Inc. at J.P. Morgan 34th Annual Healthcare Conference
12/06/15
Spark Therapeutics, Inc. at 57th American Society of Hematology (ASH) Annual Meeting & Exposition
12/03/15
Spark Therapeutics, Inc. at 2015 Genetic Rx Boston Conference
12/01/15
Spark Therapeutics, Inc. at 27th Annual Piper Jaffray Healthcare Conference
11/18/15
8:45 a.m. ET
Spark Therapeutics, Inc. at Stifel 2015 Healthcare Conference
11/12/15
4:20 p.m. PT
Spark Therapeutics, Inc. at Ophthalmology Innovation Summit (OIS) at American Academy of Ophthalmology (AAO) 2015
11/11/15
1:30 p.m. MT
Spark Therapeutics, Inc. at 24th Annual Credit Suisse Healthcare Conference
11/04/15
8:30 a.m. ET
Q3 2015 Spark Therapeutics, Inc. Earnings Conference Call
10/27/15
Spark Therapeutics, Inc. at ROTH Capital Partners Gene Therapy Corporate Access Day
10/05/15
8:30 a.m. ET
Spark Therapeutics, Inc. Conference Call
09/10/15
8:30 a.m. ET
Spark Therapeutics, Inc. Conference Call
08/05/15
8:30 a.m. ET
Q2 2015 Spark Therapeutics, Inc. Earnings Conference Call
06/25/15
Spark Therapeutics, Inc. at J.P. Morgan Cazenove European Healthcare Conference
06/24/15
Spark Therapeutics, Inc. at 2nd Annual ROTH Healthcare Day
05/06/15
8:30 a.m. ET
Q1 2015 Spark Therapeutics, Inc. Earnings Conference Call
03/04/15
10:40 a.m. ET
Spark Therapeutics, Inc. at 35th Annual Cowen and Company Health Care Conference
Supporting 
Materials: 
Download Event Supporting Material Corporate Presentation